CARING FOR PATIENTS WITH CANCER:@0.084848:0.038601:0.499679:0.038601:0.499679:0.019343:0.084848:0.019343:0.019121:0.017404:0.014276:0.005315:0.017404:0.020508:0.006515:0.011406:0.020438:0.014276:0.006515:0.012154:0.015492:0.010019:0.005315:0.012606:0.017404:0.010019:0.011712:0.006515:0.022578:0.005315:0.010019:0.016063:0.006515:0.019121:0.017404:0.017404:0.019121:0.012606:0.014276
152:@0.018436:0.038809:0.050045:0.038809:0.050045:0.019212:0.018436:0.019212:0.010536:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
29.  So SYS, Wan MLY, El-Nezami H. Probiotics-:@0.084848:0.094740:0.475758:0.094740:0.475758:0.080735:0.084848:0.080735:0.009476:0.009476:0.004738:0.012657:0.000000:0.008518:0.011203:0.007971:0.008518:0.010126:0.008518:0.004738:0.007971:0.015565:0.011682:0.010434:0.007971:0.015719:0.006347:0.008460:0.004738:0.007971:0.009168:0.003421:0.005679:0.012657:0.011118:0.007269:0.011682:0.016044:0.003421:0.007971:0.011682:0.004738:0.007971:0.010126:0.005075:0.011203:0.011665:0.003421:0.011203:0.005798:0.003421:0.011067:0.006636:0.005679
mediated suppression of cancer. :@0.121195:0.109192:0.396919:0.109192:0.396919:0.095187:0.121195:0.095187:0.016044:0.011118:0.011716:0.003421:0.011682:0.005798:0.011118:0.011716:0.004302:0.006636:0.010399:0.011665:0.011665:0.005089:0.011118:0.006636:0.006636:0.003421:0.011203:0.010434:0.004302:0.011203:0.005371:0.004297:0.011067:0.011682:0.010434:0.011067:0.011118:0.003890:0.004738:0.004738
Curr Opin:@0.396473:0.109192:0.475750:0.109192:0.475750:0.095187:0.396473:0.095187:0.013906:0.010399:0.005148:0.005148:0.004291:0.014864:0.011665:0.003421:0.010434
Oncol. :@0.121195:0.123350:0.181659:0.123350:0.181659:0.109345:0.121195:0.109345:0.014864:0.010434:0.011067:0.011203:0.003421:0.004738:0.004738
2017;29(1):62-72.:@0.181659:0.123350:0.318408:0.123350:0.318408:0.109345:0.181659:0.109345:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
30.   Pitt JM, :@0.084848:0.137073:0.186323:0.137073:0.186323:0.123068:0.084848:0.123068:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.010126:0.003421:0.005798:0.005798:0.006546:0.008244:0.015719:0.004738:0.004738
et al:@0.188142:0.137073:0.226712:0.137073:0.226712:0.123068:0.188142:0.123068:0.011118:0.005798:0.006551:0.011682:0.003421
. Fine-tuning cancer immuno-:@0.226712:0.137073:0.475775:0.137073:0.475775:0.123068:0.226712:0.123068:0.004738:0.006551:0.008296:0.003421:0.010434:0.011118:0.005679:0.005798:0.010399:0.010434:0.003421:0.010434:0.011511:0.006541:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.006551:0.003421:0.016044:0.016044:0.010399:0.010434:0.011203:0.005679
therapy: optimizing the gut microbiome.:@0.121195:0.150796:0.475767:0.150796:0.475767:0.136791:0.121195:0.136791:0.005798:0.010434:0.011118:0.005148:0.011682:0.011665:0.009168:0.004738:0.010143:0.011203:0.011665:0.005798:0.003421:0.016044:0.003421:0.007269:0.003421:0.010434:0.011511:0.010143:0.005798:0.010434:0.011118:0.010143:0.011511:0.010399:0.005798:0.010143:0.016044:0.003421:0.011067:0.005078:0.011203:0.011665:0.003421:0.011203:0.016044:0.011118:0.004738
Cancer Res.:@0.121195:0.164519:0.222145:0.164519:0.222145:0.150514:0.121195:0.150514:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.010382:0.011101:0.006636:0.004738
 :@0.222145:0.164519:0.226934:0.164519:0.226934:0.150267:0.222145:0.150267:0.004789
2016;76(16):1-6.:@0.226934:0.164519:0.354208:0.164519:0.354208:0.150514:0.226934:0.150514:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.009476:0.006312:0.004738:0.009476:0.005679:0.009476:0.004738
31.   Dasari S, :@0.084848:0.177948:0.194552:0.177948:0.194552:0.163943:0.084848:0.163943:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.012726:0.011682:0.006636:0.011682:0.005148:0.003421:0.004067:0.008518:0.004738:0.004738
et al:@0.193872:0.177948:0.229946:0.177948:0.229946:0.163943:0.193872:0.163943:0.011118:0.005798:0.004055:0.011682:0.003421
. Surfacing role of probiotics in :@0.229946:0.177948:0.480491:0.177948:0.480491:0.163943:0.229946:0.163943:0.004738:0.004057:0.008518:0.010399:0.005963:0.005371:0.011682:0.011067:0.003421:0.010434:0.011511:0.004059:0.005078:0.011203:0.003421:0.011118:0.004057:0.011203:0.005371:0.004059:0.011665:0.005080:0.011203:0.011665:0.003421:0.011203:0.005798:0.003421:0.011067:0.006636:0.004062:0.003421:0.010434:0.004738
cancer prophylaxis and therapy: a system-:@0.121195:0.191377:0.475758:0.191377:0.475758:0.177372:0.121195:0.177372:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.005015:0.011665:0.005080:0.011203:0.011665:0.010434:0.009168:0.003421:0.011682:0.008210:0.003421:0.006636:0.005029:0.011682:0.010434:0.011716:0.005029:0.005798:0.010434:0.011118:0.005148:0.011682:0.011665:0.009168:0.004738:0.005015:0.011682:0.005029:0.006636:0.009168:0.006636:0.005798:0.011118:0.016044:0.005679
atic review. :@0.121195:0.204806:0.221767:0.204806:0.221767:0.190801:0.121195:0.190801:0.011682:0.005798:0.003421:0.011067:0.004704:0.005078:0.011118:0.009476:0.003421:0.011118:0.014214:0.004738:0.004738
Clin Nutr:@0.221733:0.204806:0.291621:0.204806:0.291621:0.190801:0.221733:0.190801:0.013906:0.003421:0.003421:0.010434:0.004704:0.012657:0.010399:0.005798:0.005148
. 2016;36(6):1465-1472.:@0.291621:0.204806:0.475743:0.204806:0.475743:0.190801:0.291621:0.190801:0.004738:0.004704:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009503:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.004738
32.   Saquib J, :@0.084848:0.218236:0.201996:0.218236:0.201996:0.204230:0.084848:0.204230:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.008518:0.011682:0.011665:0.010399:0.003421:0.011665:0.005730:0.008244:0.004738:0.960224
et al:@0.202971:0.218236:0.240708:0.218236:0.240708:0.204230:0.202971:0.204230:0.011118:0.005798:0.005718:0.011682:0.003421
. Dietary intake, supplement:@0.240708:0.218236:0.475751:0.218236:0.475751:0.204230:0.240708:0.204230:0.004738:0.005720:0.012726:0.003421:0.011118:0.005798:0.011682:0.005148:0.009168:0.005730:0.003421:0.010434:0.005798:0.011682:0.008586:0.011118:0.004738:0.005718:0.006636:0.010399:0.011665:0.011665:0.003421:0.011118:0.016044:0.011118:0.010434:0.005798
use, and survival among  women diag-:@0.121195:0.231665:0.475770:0.231665:0.475770:0.217659:0.121195:0.217659:0.010399:0.006636:0.011118:0.004738:0.012059:0.011682:0.010434:0.011716:0.012059:0.006636:0.010399:0.005148:0.009476:0.003421:0.009476:0.011693:0.003421:0.012059:0.011682:0.016044:0.011203:0.010434:0.011511:0.004738:0.007312:0.014214:0.011203:0.016044:0.011118:0.010434:0.012059:0.011716:0.003421:0.011682:0.011511:0.005679
nosed with early-stage breast cancer. :@0.121195:0.245094:0.441189:0.245094:0.441189:0.231088:0.121195:0.231088:0.010434:0.011203:0.006636:0.011118:0.011716:0.005337:0.014214:0.003421:0.005798:0.010434:0.005337:0.011118:0.011682:0.005148:0.003421:0.009168:0.005679:0.006636:0.005798:0.011682:0.011511:0.011118:0.005337:0.011665:0.005080:0.011118:0.011682:0.006636:0.005798:0.005337:0.011067:0.011682:0.010434:0.011067:0.011118:0.003888:0.004738:0.004738
Nutr:@0.441787:0.245094:0.475791:0.245094:0.475791:0.231088:0.441787:0.231088:0.012657:0.010399:0.005798:0.005148
Cancer:@0.121195:0.258523:0.184550:0.258523:0.184550:0.244517:0.121195:0.244517:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148
. 2011;63:327-333:@0.184550:0.258523:0.322890:0.258523:0.322890:0.244517:0.184550:0.244517:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476
.:@0.322907:0.258523:0.327696:0.258523:0.327696:0.244271:0.322907:0.244271:0.004789
33.   Kwan  ML, :@0.084848:0.271952:0.214392:0.271952:0.214392:0.257947:0.084848:0.257947:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.010109:0.014214:0.011682:0.010434:0.004738:0.008923:0.015719:0.007902:0.004738:0.869696
et al:@0.223308:0.271952:0.268994:0.271952:0.268994:0.257947:0.223308:0.257947:0.011118:0.005798:0.013666:0.011682:0.003421
. Multivitamin use and:@0.268994:0.271952:0.475751:0.271952:0.475751:0.257947:0.268994:0.257947:0.004738:0.013666:0.015719:0.010399:0.003421:0.005798:0.003421:0.009476:0.003421:0.005798:0.011682:0.016044:0.003421:0.010434:0.013666:0.010399:0.006636:0.011118:0.013666:0.011682:0.010434:0.011716
breast-cancer outcomes  in women with:@0.121195:0.285381:0.475777:0.285381:0.475777:0.271376:0.121195:0.271376:0.011665:0.005080:0.011118:0.011682:0.006636:0.005798:0.005679:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.010553:0.011203:0.010399:0.005798:0.011067:0.011203:0.016044:0.011118:0.006636:0.004738:0.005807:0.003421:0.010434:0.010553:0.014214:0.011203:0.016044:0.011118:0.010434:0.010553:0.014214:0.003421:0.005798:0.010434
early-stage breast cancer: The Life After:@0.121195:0.298810:0.475768:0.298810:0.475768:0.284805:0.121195:0.284805:0.011118:0.011682:0.005148:0.003421:0.009168:0.005679:0.006636:0.005798:0.011682:0.011511:0.011118:0.009527:0.011665:0.005080:0.011118:0.011682:0.006636:0.005798:0.009527:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.009527:0.007286:0.010434:0.011118:0.009527:0.007902:0.003421:0.005371:0.011118:0.009527:0.012657:0.005371:0.005798:0.011118:0.005148
Cancer  Epidemiology Study. :@0.121195:0.312239:0.370647:0.312239:0.370647:0.298234:0.121195:0.298234:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.004233:0.009168:0.011665:0.003421:0.011716:0.011118:0.016044:0.003431:0.011203:0.003421:0.011203:0.011511:0.009168:0.008980:0.008518:0.005798:0.010399:0.011716:0.009168:0.004738:0.004738
Breast Can-:@0.374889:0.312239:0.475770:0.312239:0.475770:0.298234:0.374889:0.298234:0.009818:0.005148:0.011118:0.011682:0.006636:0.005798:0.008980:0.013906:0.011682:0.010434:0.005679
cer Res Treat.:@0.121195:0.325668:0.231912:0.325668:0.231912:0.311663:0.121195:0.311663:0.011067:0.011118:0.005148:0.004738:0.010382:0.011118:0.006636:0.004738:0.007286:0.005148:0.011118:0.011682:0.005798:0.004738
 :@0.181402:0.325668:0.186140:0.325668:0.186140:0.311663:0.181402:0.311663:0.004738
 2011;130:195-205.:@0.231895:0.325668:0.379710:0.325668:0.379710:0.311663:0.231895:0.311663:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
34.   Ng K, :@0.084848:0.339097:0.172164:0.339097:0.172164:0.325092:0.084848:0.325092:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.012657:0.011511:0.007216:0.010109:0.004738:0.814257
et al:@0.174646:0.339097:0.213884:0.339097:0.213884:0.325092:0.174646:0.325092:0.011118:0.005798:0.007218:0.011682:0.003421
. Multivitamin use is not associ-:@0.213884:0.339097:0.475746:0.339097:0.475746:0.325092:0.213884:0.325092:0.004738:0.007218:0.015719:0.010399:0.003421:0.005798:0.003421:0.009476:0.003421:0.005798:0.011682:0.016044:0.003438:0.010434:0.007218:0.010399:0.006636:0.011118:0.007218:0.003421:0.006636:0.007230:0.010434:0.011203:0.005798:0.007218:0.011682:0.006636:0.006636:0.011203:0.011067:0.003421:0.005679
ated with cancer  recurrence or  survival:@0.121195:0.352373:0.475756:0.352373:0.475756:0.338368:0.121195:0.338368:0.011682:0.005798:0.011118:0.011716:0.010451:0.014214:0.003421:0.005798:0.010434:0.010451:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.005704:0.005078:0.011118:0.011067:0.010399:0.005148:0.005070:0.011118:0.010434:0.011067:0.011118:0.010451:0.011203:0.005148:0.004738:0.005704:0.006636:0.010399:0.005148:0.009476:0.003421:0.009476:0.011682:0.003421
in patients with stage III colon cancer::@0.121195:0.365650:0.475768:0.365650:0.475768:0.351644:0.121195:0.351644:0.003421:0.010434:0.011563:0.011665:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.006636:0.011563:0.014214:0.003421:0.005798:0.010434:0.011563:0.006636:0.005798:0.011682:0.011511:0.011118:0.011563:0.003866:0.003866:0.003866:0.011563:0.011067:0.011203:0.003421:0.011203:0.010434:0.011563:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738
Findings from CALGB 89803. :@0.121195:0.378926:0.363082:0.378926:0.363082:0.364921:0.121195:0.364921:0.008296:0.003421:0.010434:0.011716:0.003421:0.010434:0.011511:0.006636:0.007423:0.005371:0.005077:0.011203:0.016044:0.007423:0.013906:0.012657:0.007902:0.014915:0.009818:0.007423:0.009476:0.009476:0.009476:0.009476:0.009476:0.004738:0.004738
J Clin Oncol:@0.365767:0.378926:0.471027:0.378926:0.471027:0.364921:0.365767:0.364921:0.008244:0.007423:0.013906:0.003421:0.003421:0.010434:0.007423:0.014864:0.010434:0.011067:0.011203:0.003421
.:@0.471027:0.378926:0.475765:0.378926:0.475765:0.364921:0.471027:0.364921:0.004738
2010;28:4354-436.:@0.121195:0.392202:0.264273:0.392202:0.264273:0.378197:0.121195:0.378197:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
35.   Mochamat, :@0.084848:0.405478:0.224300:0.405478:0.224300:0.391473:0.084848:0.391473:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.015719:0.011203:0.011067:0.010434:0.011682:0.016044:0.011682:0.005798:0.004738:0.665567
et al:@0.232544:0.405478:0.277563:0.405478:0.277563:0.391473:0.232544:0.391473:0.011118:0.005798:0.012999:0.011682:0.003421
. A systematic review:@0.277563:0.405478:0.475750:0.405478:0.475750:0.391473:0.277563:0.391473:0.004738:0.012999:0.012657:0.012999:0.006636:0.009168:0.006636:0.005798:0.011118:0.016044:0.011682:0.005798:0.003421:0.011067:0.012999:0.005078:0.011118:0.009476:0.003421:0.011118:0.014214
on the role of vitamins, minerals, proteins,:@0.121195:0.418754:0.475775:0.418754:0.475775:0.404749:0.121195:0.404749:0.011203:0.010434:0.007304:0.005798:0.010434:0.011118:0.007295:0.005078:0.011203:0.003421:0.011118:0.007304:0.011203:0.005371:0.007304:0.009476:0.003421:0.005798:0.011682:0.016044:0.003421:0.010434:0.006636:0.004738:0.007304:0.016044:0.003421:0.010434:0.011118:0.005148:0.011682:0.003421:0.006636:0.004738:0.007304:0.011665:0.005080:0.011203:0.005798:0.011118:0.003421:0.010434:0.006636:0.004738
and other  supplements for  the  treatment:@0.121195:0.432031:0.475767:0.432031:0.475767:0.418025:0.121195:0.418025:0.011682:0.010434:0.011716:0.008039:0.011203:0.005798:0.010434:0.011118:0.005148:0.004738:0.003286:0.006636:0.010399:0.011665:0.011665:0.003421:0.011118:0.016044:0.011118:0.010434:0.005798:0.006636:0.008039:0.005371:0.011203:0.005148:0.004738:0.003291:0.005798:0.010434:0.011118:0.004738:0.003293:0.005798:0.005078:0.011118:0.011682:0.005798:0.016044:0.011118:0.010434:0.005798
of cachexia in cancer: a European Pallia-:@0.121195:0.445307:0.475751:0.445307:0.475751:0.431302:0.121195:0.431302:0.011203:0.005371:0.006385:0.011067:0.011682:0.011067:0.010434:0.011118:0.008210:0.003421:0.011682:0.006397:0.003421:0.010434:0.006397:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.006380:0.011682:0.006397:0.009168:0.010399:0.005078:0.011203:0.011665:0.011118:0.011682:0.010434:0.006387:0.010126:0.011682:0.003421:0.003421:0.003421:0.011672:0.005679
tive Care Research Centre cachexia pro-:@0.121195:0.458583:0.475760:0.458583:0.475760:0.444578:0.121195:0.444578:0.005798:0.003421:0.009476:0.011118:0.007150:0.013906:0.011682:0.005080:0.011118:0.007150:0.010382:0.011118:0.006636:0.011118:0.011682:0.005029:0.011067:0.010434:0.007150:0.013906:0.011118:0.010434:0.005798:0.005071:0.011118:0.007150:0.011067:0.011682:0.011067:0.010434:0.011118:0.008210:0.003421:0.011682:0.007150:0.011665:0.005080:0.011203:0.005679
ject. :@0.121195:0.471859:0.162126:0.471859:0.162126:0.457854:0.121195:0.457854:0.003472:0.011118:0.011067:0.005798:0.004738:0.004738
J Cachexia, Sarcopenia and Muscle:@0.163580:0.471859:0.471029:0.471859:0.471029:0.457854:0.163580:0.457854:0.008244:0.006200:0.013906:0.011682:0.011067:0.010434:0.011118:0.008210:0.003421:0.011682:0.004738:0.006199:0.008518:0.011682:0.005148:0.011067:0.011203:0.011665:0.011118:0.010434:0.003421:0.011682:0.006209:0.011682:0.010434:0.011716:0.006209:0.015719:0.010399:0.006636:0.011067:0.003421:0.011118
.:@0.471029:0.471859:0.475767:0.471859:0.475767:0.457854:0.471029:0.457854:0.004738
2017;8:25-39.:@0.121195:0.485135:0.226370:0.485135:0.226370:0.471130:0.121195:0.471130:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.004738:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
36.   Johnson SB, :@0.084848:0.498412:0.223753:0.498412:0.223753:0.484406:0.084848:0.484406:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.008244:0.011203:0.010434:0.010434:0.006636:0.011203:0.010434:0.006158:0.008518:0.009818:0.004738:0.530939
et al:@0.225190:0.498412:0.263375:0.498412:0.263375:0.484406:0.225190:0.484406:0.011118:0.005798:0.006166:0.011682:0.003421
. Use of alternative medi-:@0.263375:0.498412:0.475767:0.498412:0.475767:0.484406:0.263375:0.484406:0.004738:0.006175:0.011203:0.006636:0.011118:0.006175:0.011203:0.005371:0.006166:0.011682:0.003421:0.005798:0.011118:0.005506:0.010434:0.011682:0.005798:0.003421:0.009476:0.011118:0.006175:0.016044:0.011118:0.011716:0.003421:0.005679
cine for cancer and its impact on survival. :@0.121195:0.511688:0.468178:0.511688:0.468178:0.497683:0.121195:0.497683:0.011067:0.003421:0.010434:0.011118:0.004079:0.005371:0.011203:0.005148:0.004073:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004073:0.011682:0.010434:0.011716:0.004079:0.003421:0.005798:0.006636:0.004088:0.003421:0.016044:0.011665:0.011682:0.011067:0.005798:0.004088:0.011203:0.010434:0.004088:0.006636:0.010399:0.005148:0.009476:0.003421:0.009476:0.011682:0.003421:0.004738:0.004738
J:@0.467528:0.511688:0.475772:0.511688:0.475772:0.497683:0.467528:0.497683:0.008244
National Cancer Instit:@0.121195:0.524964:0.303972:0.524964:0.303972:0.510959:0.121195:0.510959:0.012657:0.011682:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.006585:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.006585:0.003866:0.010434:0.006636:0.005798:0.003421:0.005798
. 2018;110(1)121-124.:@0.303972:0.524964:0.475753:0.524964:0.475753:0.510959:0.303972:0.510959:0.004738:0.006577:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.006312:0.009503:0.006312:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
Doi: http://doi.org/10.1093/jnci.djx145.:@0.121195:0.538240:0.436582:0.538240:0.436582:0.524235:0.121195:0.524235:0.012726:0.011203:0.003421:0.004738:0.004738:0.010434:0.005798:0.005798:0.011665:0.004738:0.007475:0.007475:0.011716:0.011203:0.003421:0.004738:0.011203:0.005148:0.011511:0.007475:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.009476:0.007475:0.003472:0.010434:0.011067:0.003421:0.004738:0.011716:0.003472:0.008210:0.009476:0.009476:0.009476:0.004738
37.   Arends J, :@0.084848:0.551516:0.200363:0.551516:0.200363:0.537511:0.084848:0.537511:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.012657:0.005073:0.011118:0.010434:0.011716:0.006636:0.003813:0.008244:0.004738:0.477086
et al:@0.199430:0.551516:0.235264:0.551516:0.235264:0.537511:0.199430:0.537511:0.011118:0.005798:0.003814:0.011682:0.003421
. ESPEN guidelines on nutrition :@0.235264:0.551516:0.480515:0.551516:0.480515:0.537511:0.235264:0.537511:0.004738:0.003814:0.009168:0.008518:0.010126:0.009168:0.012657:0.003814:0.011511:0.010399:0.003421:0.011716:0.011118:0.003421:0.003421:0.010434:0.011118:0.006636:0.003814:0.011203:0.010434:0.003806:0.010434:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434:0.004738
in cancer patients. :@0.121195:0.564793:0.291811:0.564793:0.291811:0.550787:0.121195:0.550787:0.003421:0.010434:0.010109:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.010109:0.011665:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.006636:0.004738:0.004738
Clin Nutr. :@0.297182:0.564793:0.381951:0.564793:0.381951:0.550787:0.297182:0.550787:0.013906:0.003421:0.003421:0.010434:0.010109:0.012657:0.010399:0.005798:0.005148:0.004738:0.004738
2017;36(1)::@0.387305:0.564793:0.475734:0.564793:0.475734:0.550787:0.387305:0.550787:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738
11-48.:@0.121195:0.578069:0.169515:0.578069:0.169515:0.564064:0.121195:0.564064:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
38.   ACS Guidelines for  Nutrition  and Physical:@0.084848:0.591792:0.475763:0.591792:0.475763:0.577787:0.084848:0.577787:0.009476:0.009476:0.004738:0.012657:0.004738:-0.004738:0.012657:0.013906:0.008518:0.008621:0.014915:0.010399:0.003421:0.011716:0.011118:0.003421:0.003438:0.010434:0.011118:0.006636:0.008621:0.005371:0.011203:0.005148:0.004738:0.003874:0.012657:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434:0.004738:0.003869:0.011682:0.010434:0.011716:0.008621:0.010126:0.010434:0.009168:0.006636:0.003421:0.011067:0.011682:0.003421
Activity. https://www.cancer.org/healthy/:@0.121195:0.605515:0.475756:0.605515:0.475756:0.591510:0.121195:0.591510:0.012657:0.011067:0.005798:0.003421:0.009476:0.003421:0.005798:0.009168:0.004738:0.012760:0.010434:0.005798:0.005798:0.011665:0.006636:0.004738:0.007475:0.007475:0.014214:0.014214:0.014214:0.004738:0.011067:0.011682:0.010434:0.011067:0.011118:0.003888:0.004738:0.011203:0.005148:0.011511:0.007475:0.010434:0.011118:0.011682:0.003421:0.005798:0.010434:0.009168:0.007475
eat-healthy-get-active/acs-guidelines-nu-:@0.121195:0.619238:0.467798:0.619238:0.467798:0.605233:0.121195:0.605233:0.011118:0.011682:0.005798:0.005679:0.010434:0.011118:0.011682:0.003421:0.005798:0.010434:0.009168:0.005679:0.011511:0.011118:0.005798:0.005679:0.011682:0.011067:0.005798:0.003421:0.009476:0.011118:0.007475:0.011682:0.011067:0.006636:0.005679:0.011511:0.010399:0.003421:0.011716:0.011118:0.003421:0.003421:0.010434:0.011118:0.006636:0.005679:0.010434:0.010399:0.005679
trition-physical-activity-cancer-prevention/:@0.121195:0.632961:0.474205:0.632961:0.474205:0.618956:0.121195:0.618956:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434:0.005679:0.011665:0.010434:0.009168:0.006636:0.003421:0.011067:0.011682:0.003421:0.005679:0.011682:0.011067:0.005798:0.003421:0.009476:0.003421:0.005798:0.009168:0.005679:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.005679:0.011665:0.005090:0.011118:0.009476:0.011118:0.010434:0.005798:0.003421:0.011203:0.010434:0.007475
summary.html. Accessed 7 January 2018.:@0.121195:0.646684:0.461332:0.646684:0.461332:0.632679:0.121195:0.632679:0.006636:0.010399:0.016044:0.016044:0.011682:0.005148:0.009168:0.004738:0.010434:0.005798:0.016044:0.003421:0.004738:0.004738:0.012657:0.011067:0.011067:0.011118:0.006636:0.006636:0.011118:0.011716:0.004738:0.009476:0.004738:0.008244:0.011682:0.010434:0.010399:0.011682:0.005148:0.009168:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738
39.   NCCN  Clinical Practice  Guidelines in  On-:@0.084848:0.660407:0.475758:0.660407:0.475758:0.646402:0.084848:0.646402:0.009476:0.009476:0.004738:0.012657:0.004738:-0.004738:0.012657:0.013906:0.013906:0.012657:0.004738:0.003216:0.013906:0.003421:0.003421:0.010434:0.003421:0.011067:0.011682:0.003421:0.007971:0.010126:0.005148:0.011682:0.011067:0.005798:0.003421:0.011067:0.011118:0.004738:0.003216:0.014915:0.010399:0.003421:0.011716:0.011118:0.003421:0.003421:0.010434:0.011118:0.006636:0.007971:0.003421:0.010434:0.004738:0.003222:0.014864:0.010434:0.044244
cology:  Survivorship Version  I;  2015. Avail-:@0.121195:0.674130:0.475751:0.674130:0.475751:0.660125:0.121195:0.660125:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168:0.004738:0.004738:0.003799:0.008518:0.010399:0.005148:0.009476:0.003421:0.009476:0.011203:0.005148:0.006636:0.010434:0.003421:0.011665:0.008552:0.010281:0.011118:0.005148:0.006636:0.003421:0.011203:0.010434:0.004738:0.003801:0.003866:0.004738:0.004738:0.003806:0.009476:0.009476:0.009476:0.009476:0.004738:0.008552:0.011400:0.009476:0.011682:0.003421:0.003431:0.005679
able online:  http://www.nccn.org/profes-:@0.121195:0.687853:0.475775:0.687853:0.475775:0.673848:0.121195:0.673848:0.011682:0.011665:0.003421:0.011118:0.010673:0.011203:0.010434:0.003421:0.003421:0.010434:0.011118:0.004738:0.004738:0.005927:0.010434:0.005798:0.005798:0.011665:0.004738:0.007475:0.007475:0.014214:0.014214:0.014214:0.004738:0.010434:0.011067:0.011067:0.010434:0.004738:0.011203:0.005148:0.011511:0.007475:0.011665:0.005078:0.011203:0.005371:0.011118:0.006636:0.005679
sionals/physician_gls/pdf/survivorship.pdf  .:@0.121195:0.701576:0.475760:0.701576:0.475760:0.687571:0.121195:0.687571:0.006636:0.003421:0.011203:0.010434:0.011682:0.003421:0.006636:0.007475:0.011665:0.010434:0.009168:0.006636:0.003421:0.011067:0.003421:0.011682:0.010434:0.008552:0.011511:0.003421:0.006636:0.007475:0.011665:0.011716:0.005371:0.007475:0.006636:0.010399:0.005148:0.009476:0.003421:0.009476:0.011203:0.005148:0.006636:0.010434:0.003421:0.011665:0.004738:0.011665:0.011716:0.005371:0.004738:0.005875:0.004738
Accessed 7 January 2018.:@0.121195:0.715299:0.336300:0.715299:0.336300:0.701294:0.121195:0.701294:0.012657:0.011067:0.011067:0.011118:0.006636:0.006636:0.011118:0.011716:0.004738:0.009476:0.004738:0.008244:0.011682:0.010434:0.010399:0.011682:0.005148:0.009168:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738
40.   Harvie M. Nutritional supplements and can-:@0.084848:0.729022:0.475767:0.729022:0.475767:0.715017:0.084848:0.715017:0.009476:0.009476:0.004738:0.012657:0.004738:-0.004738:0.011682:0.011682:0.005148:0.009476:0.003421:0.011118:0.004122:0.015719:0.004738:0.004105:0.012657:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.004112:0.006636:0.010399:0.011665:0.011665:0.003421:0.011118:0.016044:0.011118:0.010434:0.005798:0.006636:0.004122:0.011682:0.010434:0.011716:0.004114:0.011067:0.011682:0.010434:-0.055568
cer:  potential  benefits  and  proven  harm.:@0.121195:0.742745:0.475762:0.742745:0.475762:0.728740:0.121195:0.728740:0.011067:0.011118:0.005148:0.004738:0.004738:0.003563:0.011665:0.011203:0.005798:0.011118:0.010434:0.005798:0.003421:0.011682:0.003421:0.004738:0.003573:0.011665:0.011118:0.010434:0.011118:0.004165:0.004165:0.005798:0.006636:0.004738:0.003565:0.011682:0.010434:0.011716:0.004738:0.003571:0.011665:0.005080:0.011203:0.009476:0.011118:0.010434:0.004738:0.003568:0.010434:0.011682:0.005620:0.016044:0.004738
Am Soc Clin Oncol Educ Book:@0.121195:0.756469:0.376965:0.756469:0.376965:0.742463:0.121195:0.742463:0.012657:0.016044:0.006183:0.008518:0.011203:0.011067:0.006192:0.013906:0.003421:0.003421:0.010434:0.006192:0.014864:0.010434:0.011067:0.011203:0.003421:0.006192:0.009168:0.011716:0.010399:0.011067:0.006192:0.009818:0.011203:0.011203:0.008586
. 2014;e478-:@0.376965:0.756469:0.475734:0.756469:0.475734:0.742463:0.376965:0.742463:0.004738:0.006166:0.009476:0.009476:0.009476:0.009476:0.004738:0.011118:0.009476:0.009476:0.009476:0.005679
86.:@0.121195:0.770192:0.144885:0.770192:0.144885:0.756186:0.121195:0.756186:0.009476:0.009476:0.004738
41.   Gallagner EJ, LeRoith D. Obesity and dia-:@0.084848:0.783915:0.475768:0.783915:0.475768:0.769909:0.084848:0.769909:0.009476:0.009476:0.004738:0.012657:0.004738:-0.004738:0.014915:0.011682:0.003421:0.003421:0.011682:0.011511:0.010434:0.011118:0.005148:0.007064:0.009168:0.008244:0.004738:0.007064:0.007902:0.011118:0.010382:0.011203:0.003421:0.005798:0.010434:0.007047:0.012726:0.004738:0.007064:0.014864:0.011665:0.011118:0.006636:0.003421:0.005798:0.009168:0.007064:0.011682:0.010434:0.011716:0.007064:0.011716:0.003421:0.011682:-0.135413
betes:  the  increased risk of  cancer  and:@0.121195:0.797638:0.475768:0.797638:0.475768:0.783632:0.121195:0.783632:0.011665:0.011118:0.005798:0.011118:0.006636:0.004738:0.004738:0.005121:0.005798:0.010434:0.011118:0.004738:0.005118:0.003421:0.010434:0.011067:0.005078:0.011118:0.011682:0.006636:0.011118:0.011716:0.009869:0.005148:0.003421:0.006636:0.008586:0.009869:0.011203:0.005371:0.004738:0.005119:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.005118:0.011682:0.010434:0.011716
cancer-related  mortality. :@0.121195:0.811361:0.349109:0.811361:0.349109:0.797355:0.121195:0.797355:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.005679:0.005071:0.011118:0.003421:0.011682:0.005798:0.011118:0.011716:0.004738:0.015897:0.016044:0.011203:0.005148:0.005798:0.011682:0.003421:0.003421:0.005798:0.009168:0.004738:0.004738
Physiol  Rev:@0.365001:0.811361:0.471022:0.811361:0.471022:0.797355:0.365001:0.797355:0.010126:0.010434:0.009168:0.006636:0.003421:0.011203:0.003421:0.004738:0.015899:0.010382:0.011118:0.009476
.:@0.471022:0.811361:0.475760:0.811361:0.475760:0.797355:0.471022:0.797355:0.004738
2015;95:727-748.:@0.121195:0.825084:0.254797:0.825084:0.254797:0.811079:0.121195:0.811079:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
42.   Ligibel JA, :@0.084848:0.838807:0.209895:0.838807:0.209895:0.824802:0.084848:0.824802:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.007902:0.003421:0.011511:0.003421:0.011665:0.011118:0.003421:0.005863:0.008244:0.012657:0.004738:0.049677
et al:@0.211010:0.838807:0.248883:0.838807:0.248883:0.824802:0.211010:0.824802:0.011118:0.005798:0.005853:0.011682:0.003421
. American Society of Clini-:@0.248883:0.838807:0.475750:0.838807:0.475750:0.824802:0.248883:0.824802:0.004738:0.005853:0.012657:0.016044:0.011118:0.005148:0.003421:0.011067:0.011682:0.010434:0.005850:0.008518:0.011203:0.011067:0.003421:0.011118:0.005798:0.009168:0.005855:0.011203:0.005371:0.005853:0.013906:0.003421:0.003421:0.010434:0.003421:0.005679
cal Oncology Position Statement on Obesi-:@0.121195:0.852671:0.475767:0.852671:0.475767:0.838666:0.121195:0.838666:0.011067:0.011682:0.003421:0.004396:0.014864:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168:0.004396:0.010126:0.011203:0.006636:0.003421:0.005798:0.003421:0.011203:0.010434:0.004396:0.008518:0.005798:0.011682:0.005798:0.011118:0.016044:0.011118:0.010434:0.005798:0.004386:0.011203:0.010434:0.004387:0.014864:0.011665:0.011118:0.006636:0.003421:0.005679
ty and Cancer. :@0.121195:0.866535:0.252854:0.866535:0.252854:0.852530:0.121195:0.852530:0.005798:0.009168:0.005644:0.011682:0.010434:0.011716:0.005644:0.013906:0.011682:0.010434:0.011067:0.011118:0.003890:0.004738:0.004738
J Clin Oncol.:@0.253761:0.866535:0.360201:0.866535:0.360201:0.852530:0.253761:0.852530:0.008244:0.005644:0.013906:0.003421:0.003421:0.010434:0.005644:0.014864:0.010434:0.011067:0.011203:0.003421:0.004738
 2014;32:3568-:@0.360201:0.866535:0.475772:0.866535:0.475772:0.852530:0.360201:0.852530:0.005644:0.009476:0.009476:0.009476:0.009489:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.009476:0.005679
3574.:@0.121195:0.880399:0.163836:0.880399:0.163836:0.866394:0.121195:0.866394:0.009476:0.009476:0.009476:0.009476:0.004738
43.   Park J, :@0.084848:0.894264:0.180624:0.894264:0.180624:0.880258:0.084848:0.880258:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.010126:0.011682:0.005148:0.008586:0.006166:0.008244:0.004738:0.004738
et al:@0.182052:0.894264:0.220246:0.894264:0.220246:0.880258:0.182052:0.880258:0.011118:0.005798:0.006175:0.011682:0.003421
. Obesity and cancer – mech-:@0.220246:0.894264:0.475758:0.894264:0.475758:0.880258:0.220246:0.880258:0.004738:0.006175:0.014864:0.011665:0.011118:0.006636:0.003421:0.005798:0.009168:0.006175:0.011682:0.010434:0.011716:0.006175:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.006164:0.008552:0.006175:0.016044:0.011118:0.011067:0.010434:0.005679
anisms underlying  tumour  progression :@0.121195:0.908128:0.480489:0.908128:0.480489:0.894122:0.121195:0.894122:0.011682:0.010434:0.003421:0.006636:0.016044:0.006636:0.019995:0.010399:0.010434:0.011716:0.011118:0.005148:0.003421:0.009168:0.003421:0.010434:0.011511:0.004738:0.015249:0.005798:0.010399:0.016044:0.011203:0.010399:0.005148:0.004738:0.015240:0.011665:0.005080:0.011203:0.011511:0.005071:0.011118:0.006636:0.006636:0.003421:0.011203:0.010434:0.004738
and recurrence. :@0.121195:0.921992:0.273961:0.921992:0.273961:0.907987:0.121195:0.907987:0.011682:0.010434:0.011716:0.017840:0.005077:0.011118:0.011067:0.010399:0.005148:0.005073:0.011118:0.010434:0.011067:0.011118:0.004738:0.004738
Nat  Rev Endocrinol:@0.287039:0.921992:0.471036:0.921992:0.471036:0.907987:0.287039:0.907987:0.012657:0.011682:0.005798:0.004738:0.013090:0.010382:0.011118:0.009476:0.017840:0.009168:0.010434:0.011716:0.011203:0.011067:0.005148:0.003421:0.010434:0.011203:0.003421
. :@0.471036:0.921992:0.480512:0.921992:0.480512:0.907987:0.471036:0.907987:0.004738:0.004738
2014;10(8):455-465.:@0.121195:0.935856:0.276896:0.935856:0.276896:0.921851:0.121195:0.921851:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
44.   Makari-Judson G, :@0.524242:0.094681:0.710220:0.094681:0.710220:0.080676:0.524242:0.080676:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.015719:0.011682:0.008586:0.011682:0.005148:0.003421:0.005679:0.008244:0.010399:0.011716:0.006636:0.011203:0.010434:0.004688:0.014915:0.004738:0.004738
et al:@0.710167:0.094681:0.746873:0.094681:0.746873:0.080676:0.710167:0.080676:0.011118:0.005798:0.004687:0.011682:0.003421
. Weight gain follow-:@0.746873:0.094681:0.915128:0.094681:0.915128:0.080676:0.746873:0.080676:0.004738:0.004687:0.015616:0.011118:0.003421:0.011511:0.010434:0.005798:0.004687:0.011511:0.011682:0.003421:0.010434:0.004687:0.005371:0.011203:0.003421:0.003421:0.011203:0.014214:0.005679
ing  breast-cancer  diagnosis: implication:@0.560589:0.108663:0.915150:0.108663:0.915150:0.094657:0.560589:0.094657:0.003421:0.010434:0.011511:0.004738:0.007940:0.011665:0.005080:0.011118:0.011682:0.006636:0.005798:0.005679:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.007938:0.011716:0.003421:0.011682:0.011511:0.010434:0.011203:0.006636:0.003421:0.006636:0.004738:0.012691:0.003421:0.016044:0.011665:0.003421:0.003421:0.011067:0.011682:0.005798:0.003421:0.011203:0.010434
and  proposed  mechanisms. :@0.560589:0.122645:0.805640:0.122645:0.805640:0.108639:0.560589:0.108639:0.011682:0.010434:0.011716:0.004738:0.004233:0.011665:0.005080:0.011203:0.011665:0.011203:0.006636:0.011118:0.011716:0.004738:0.004230:0.016044:0.011118:0.011067:0.010434:0.011682:0.010434:0.003421:0.006636:0.016044:0.006636:0.004738:0.004738
World  J  Clin:@0.809882:0.122645:0.915154:0.122645:0.915154:0.108639:0.809882:0.108639:0.016420:0.011203:0.005148:0.003421:0.011716:0.004738:0.004230:0.008244:0.004738:0.004232:0.013906:0.003421:0.003421:0.010434
Oncol.:@0.560589:0.136626:0.616315:0.136626:0.616315:0.122621:0.560589:0.122621:0.014864:0.010434:0.011067:0.011203:0.003421:0.004738
 2014;5(3):272-282.:@0.616315:0.136626:0.767278:0.136626:0.767278:0.122621:0.616315:0.122621:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
45.   Gonzalez  MC, :@0.524242:0.150467:0.686710:0.150467:0.686710:0.136462:0.524242:0.136462:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.014915:0.011203:0.010434:0.007269:0.011682:0.003421:0.011118:0.007269:0.004738:0.004971:0.015719:0.013906:0.004738:0.574083
et al:@0.691677:0.150467:0.733411:0.150467:0.733411:0.136462:0.691677:0.136462:0.011118:0.005798:0.009715:0.011682:0.003421
. Obesity paradox in:@0.733411:0.150467:0.915128:0.150467:0.915128:0.136462:0.733411:0.136462:0.004738:0.009715:0.014864:0.011665:0.011118:0.006636:0.003421:0.005798:0.009168:0.009715:0.011665:0.011682:0.005148:0.011682:0.011716:0.011203:0.008210:0.009715:0.003421:0.010434
cancer: new insights provided by body:@0.560589:0.164308:0.915128:0.164308:0.915128:0.150302:0.560589:0.150302:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.011049:0.010434:0.011118:0.014214:0.011049:0.003421:0.010434:0.006636:0.003421:0.011511:0.010434:0.005798:0.006636:0.011049:0.011665:0.005080:0.011203:0.009476:0.003421:0.011716:0.011118:0.011716:0.011049:0.011665:0.009168:0.011049:0.011665:0.011203:0.011716:0.009168
composition. :@0.560589:0.178148:0.672161:0.178148:0.672161:0.164143:0.560589:0.164143:0.011067:0.011203:0.016044:0.011665:0.011203:0.006636:0.003421:0.005798:0.003421:0.011203:0.010434:0.004738:0.004738
Clin Nutr.:@0.672144:0.178148:0.746804:0.178148:0.746804:0.164143:0.672144:0.164143:0.013906:0.003421:0.003421:0.010434:0.004738:0.012657:0.010399:0.005798:0.005148:0.004738
 2014;99:999-1005.:@0.746787:0.178148:0.894603:0.178148:0.894603:0.164143:0.746787:0.164143:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.004738
46.   Bruggerman  AR, :@0.524225:0.191989:0.707196:0.191989:0.707196:0.177984:0.524225:0.177984:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.009818:0.005148:0.010399:0.011511:0.011511:0.011118:0.005612:0.016044:0.011682:0.010434:0.004738:0.006093:0.012657:0.010382:0.004738:0.493201
et al:@0.713280:0.191989:0.756126:0.191989:0.756126:0.177984:0.713280:0.177984:0.011118:0.005798:0.010827:0.011682:0.003421
. Cancer cachex-:@0.756126:0.191989:0.915128:0.191989:0.915128:0.177984:0.756126:0.177984:0.004738:0.010827:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.010827:0.011067:0.011682:0.011067:0.010434:0.011118:0.008210:0.005679
ia: beyond  weight  loss. :@0.560572:0.205677:0.772610:0.205677:0.772610:0.191671:0.560572:0.191671:0.003421:0.011682:0.004738:0.011015:0.011665:0.011118:0.009168:0.011203:0.010434:0.011716:0.004738:0.006269:0.014214:0.011118:0.003421:0.011511:0.010434:0.005798:0.004738:0.006264:0.003421:0.011203:0.006636:0.006636:0.004738:0.004738
Clinical Review:@0.778887:0.205677:0.910412:0.205677:0.910412:0.191671:0.778887:0.191671:0.013906:0.003421:0.003421:0.010434:0.003421:0.011067:0.011693:0.003421:0.011015:0.010382:0.011118:0.009476:0.003421:0.011118:0.014214
.:@0.910412:0.205677:0.915150:0.205677:0.915150:0.191671:0.910412:0.191671:0.004738
2016;12(11):1163-1171.:@0.560572:0.219364:0.744700:0.219364:0.744700:0.205359:0.560572:0.205359:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.004738
47.  Laviano A, Di Lazzaro Giraldi G, Koverech A.:@0.524225:0.233052:0.915135:0.233052:0.915135:0.219047:0.524225:0.219047:0.009476:0.009476:0.004738:0.012657:0.000000:0.007902:0.011682:0.009476:0.003421:0.011682:0.010434:0.011203:0.003250:0.012657:0.004738:0.003250:0.012726:0.003421:0.003250:0.007902:0.011682:0.007269:0.007269:0.011682:0.005080:0.011203:0.003250:0.014915:0.003421:0.005148:0.011682:0.003421:0.011716:0.003421:0.003264:0.014915:0.004738:0.003250:0.010109:0.011203:0.009476:0.011118:0.005073:0.011118:0.011067:0.010434:0.003250:0.012657:0.004738
Does nutrition support have a role in man-:@0.560572:0.246740:0.915140:0.246740:0.915140:0.232735:0.560572:0.232735:0.012726:0.011203:0.011118:0.006636:0.005918:0.010434:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434:0.005908:0.006636:0.010399:0.011665:0.011665:0.011203:0.005148:0.005798:0.005910:0.010434:0.011682:0.009476:0.011118:0.005918:0.011682:0.005918:0.005077:0.011203:0.003421:0.011118:0.005918:0.003421:0.010434:0.005918:0.016044:0.011682:0.010434:0.005679
aging  cancer  cachexia? :@0.560572:0.260428:0.781350:0.260428:0.781350:0.246422:0.560572:0.246422:0.011682:0.011511:0.003421:0.010434:0.011511:0.004738:0.004353:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.004348:0.011067:0.011682:0.011067:0.010434:0.011118:0.008210:0.003421:0.011682:0.010109:0.004738
Curr  Opin Sup-:@0.785699:0.260428:0.915130:0.260428:0.915130:0.246422:0.785699:0.246422:0.013906:0.010399:0.005148:0.005148:0.004738:0.004346:0.014864:0.011665:0.003421:0.010434:0.009100:0.008518:0.010399:0.011665:0.005679
port Palliat Care:@0.560572:0.274116:0.695269:0.274116:0.695269:0.260110:0.560572:0.260110:0.011665:0.011203:0.005148:0.005798:0.004738:0.010126:0.011682:0.003421:0.003421:0.003421:0.011682:0.005798:0.004738:0.013906:0.011682:0.005148:0.011118
. 2016;10(4):288-292.:@0.695269:0.274116:0.860446:0.274116:0.860446:0.260110:0.695269:0.260110:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
48.   Dev  R, :@0.524225:0.287803:0.623610:0.287803:0.623610:0.273798:0.524225:0.273798:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.012726:0.011118:0.009476:0.004738:0.005123:0.010382:0.004738:0.437421
et al:@0.628733:0.287803:0.670604:0.287803:0.670604:0.273798:0.628733:0.273798:0.011118:0.005798:0.009852:0.011682:0.003421
. The evolving approach to:@0.670604:0.287803:0.915133:0.287803:0.915133:0.273798:0.670604:0.273798:0.004738:0.009852:0.007286:0.010434:0.011118:0.009852:0.011118:0.009476:0.011203:0.003421:0.009476:0.003421:0.010434:0.011511:0.009852:0.011682:0.011665:0.011665:0.005085:0.011203:0.011682:0.011067:0.010434:0.009852:0.005798:0.011203
management of cancer cachexia. :@0.560572:0.301491:0.857825:0.301491:0.857825:0.287486:0.560572:0.287486:0.016044:0.011682:0.010434:0.011682:0.011511:0.011118:0.016044:0.011118:0.010434:0.005798:0.005376:0.011203:0.005371:0.005388:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.005379:0.011067:0.011682:0.011067:0.010434:0.011118:0.008210:0.003421:0.011682:0.004738:0.004738
Oncol-:@0.858475:0.301491:0.915142:0.301491:0.915142:0.287486:0.858475:0.287486:0.014864:0.010434:0.011067:0.011203:0.003421:0.005679
ogy:@0.560572:0.315179:0.592454:0.315179:0.592454:0.301174:0.560572:0.301174:0.011203:0.011511:0.009168
. 2017;31(1):23-32.:@0.592454:0.315179:0.738680:0.315179:0.738680:0.301174:0.592454:0.301174:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
49.   Porporato PE. Understanding cachexia as a :@0.524225:0.328867:0.919871:0.328867:0.919871:0.314861:0.524225:0.314861:0.009476:0.009476:0.004738:0.012657:0.004738:-0.004738:0.010126:0.011203:0.005148:0.011665:0.011203:0.005148:0.011682:0.005798:0.011203:0.003472:0.010126:0.009168:0.004738:0.003489:0.011203:0.010434:0.011716:0.011118:0.005148:0.006636:0.005798:0.011682:0.010434:0.011716:0.003421:0.010434:0.011511:0.003477:0.011067:0.011682:0.011067:0.010434:0.011118:0.008210:0.003421:0.011682:0.003489:0.011682:0.006636:0.003489:0.011682:0.081431
cancer metabolism syndrome. :@0.560572:0.342554:0.825383:0.342554:0.825383:0.328549:0.560572:0.328549:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.008193:0.016044:0.011118:0.005798:0.011682:0.011665:0.011203:0.003421:0.003421:0.006636:0.016044:0.008193:0.006636:0.009168:0.010434:0.011716:0.005082:0.011203:0.016044:0.011118:0.004738:0.004738
Oncogen-:@0.828838:0.342554:0.915128:0.342554:0.915128:0.328549:0.828838:0.328549:0.014864:0.010434:0.011067:0.011203:0.011511:0.011118:0.010415:0.005679
esi:@0.560572:0.356242:0.581747:0.356242:0.581747:0.342237:0.560572:0.342237:0.011118:0.006636:0.003421
s. 2016;5:200. Doi:10.1038/oncsis.2016.3.:@0.581747:0.356242:0.904763:0.356242:0.904763:0.342237:0.581747:0.342237:0.006636:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.004738:0.009476:0.009476:0.009476:0.004738:0.004738:0.012726:0.011203:0.003421:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.009476:0.007475:0.011203:0.010434:0.011067:0.006636:0.003421:0.006636:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.004738
50.   Thompson  KL, :@0.524225:0.369930:0.680212:0.369930:0.680212:0.355925:0.524225:0.355925:0.009479:0.009479:0.004731:0.004738:0.007919:0.000000:0.006944:0.010092:0.010861:0.015702:0.011323:0.006294:0.010861:0.010092:0.004738:0.006272:0.009767:0.007560:0.004396:0.004738
et al:@0.686460:0.369930:0.728468:0.369930:0.728468:0.355925:0.686460:0.355925:0.010776:0.005456:0.011015:0.011340:0.003421
. Oncology Evidence-:@0.728126:0.369930:0.915145:0.369930:0.915145:0.355925:0.728126:0.355925:0.004396:0.011015:0.014522:0.010092:0.010724:0.010861:0.003079:0.010861:0.011169:0.008826:0.011015:0.008826:0.009134:0.003079:0.011374:0.010776:0.010092:0.010724:0.010776:0.005679
Based Nutrition Practice Guideline for Adults.:@0.560572:0.383618:0.915152:0.383618:0.915152:0.369612:0.560572:0.369612:0.009476:0.011340:0.006294:0.010776:0.011374:0.004507:0.012315:0.010057:0.005456:0.004806:0.003079:0.005456:0.003079:0.010861:0.010092:0.004507:0.009784:0.004806:0.011340:0.010724:0.005456:0.003079:0.010724:0.010776:0.004507:0.014573:0.010057:0.003079:0.011374:0.010776:0.003079:0.003079:0.010092:0.010776:0.004505:0.005029:0.010861:0.004806:0.004507:0.012315:0.011374:0.010057:0.003079:0.005456:0.006294:0.004738
J Acad Nutr Diet:@0.560572:0.397306:0.692087:0.397306:0.692087:0.383300:0.560572:0.383300:0.007902:0.004396:0.012315:0.010724:0.011340:0.011374:0.004396:0.012315:0.010057:0.005456:0.004806:0.004396:0.012384:0.003079:0.010776:0.005798
. 2017;117(22):297-310.:@0.691745:0.397306:0.868348:0.397306:0.868348:0.383300:0.691745:0.383300:0.004396:0.004396:0.009134:0.009134:0.009134:0.009134:0.004396:0.009134:0.009134:0.009134:0.005969:0.009134:0.009134:0.005969:0.004396:0.009134:0.009134:0.009134:0.005337:0.009134:0.009134:0.009134:0.004738
51.   Ezeoke  CC,  Moreley  JE.  Pathophysiology:@0.524225:0.410993:0.915140:0.410993:0.915140:0.396988:0.524225:0.396988:0.009476:0.009476:0.004738:0.012657:0.004738:-0.004738:0.009168:0.007269:0.011118:0.011203:0.008586:0.011118:0.004738:0.004635:0.013906:0.013906:0.004738:0.004738:0.004639:0.015719:0.011203:0.005075:0.011118:0.003421:0.011118:0.009168:0.004738:0.004644:0.008244:0.009168:0.004738:0.004738:0.004640:0.010126:0.011682:0.005798:0.010434:0.011203:0.011665:0.010434:0.009168:0.006636:0.003421:0.011203:0.003421:0.011203:0.011511:-0.028865
of anorexia in the cancer cachexia syn-:@0.560572:0.424681:0.915138:0.424681:0.915138:0.410676:0.560572:0.410676:0.011203:0.005371:0.008809:0.011682:0.010434:0.011203:0.005073:0.011118:0.008210:0.003421:0.011682:0.008809:0.003421:0.010434:0.008809:0.005798:0.010434:0.011118:0.008809:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.008809:0.011067:0.011682:0.011067:0.010434:0.011118:0.008210:0.003421:0.011682:0.008809:0.006636:0.009168:0.010434:0.005679
drome. :@0.560572:0.438369:0.625208:0.438369:0.625208:0.424364:0.560572:0.424364:0.011716:0.005078:0.011203:0.016044:0.011118:0.004738:0.004738
J Cachexia, Sarcopenia and Mus-:@0.626851:0.438369:0.915145:0.438369:0.915145:0.424364:0.626851:0.424364:0.008244:0.006397:0.013906:0.011682:0.011067:0.010434:0.011118:0.008210:0.003421:0.011682:0.004738:0.006397:0.008518:0.011682:0.005148:0.011067:0.011203:0.011665:0.011118:0.010434:0.003421:0.011682:0.006397:0.011682:0.010434:0.011716:0.006397:0.015719:0.010399:0.006636:0.005679
cle:@0.560572:0.452057:0.586177:0.452057:0.586177:0.438051:0.560572:0.438051:0.011067:0.003421:0.011118
. 2015;6:287-302.:@0.586177:0.452057:0.719779:0.452057:0.719779:0.438051:0.586177:0.438051:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
52.   Hebuterne  X, :@0.524225:0.465744:0.676787:0.465744:0.676787:0.451739:0.524225:0.451739:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.011682:0.011118:0.011665:0.010399:0.005798:0.011118:0.005501:0.010434:0.011118:0.004738:0.002752:0.010417:0.004738:0.125420
et al:@0.679533:0.465744:0.719044:0.465744:0.719044:0.451739:0.679533:0.451739:0.011118:0.005798:0.007492:0.011682:0.003421
. Prevalence of malnu-:@0.719044:0.465744:0.915123:0.465744:0.915123:0.451739:0.719044:0.451739:0.004738:0.007492:0.010126:0.005075:0.011118:0.009476:0.011682:0.003421:0.011118:0.010434:0.011067:0.011118:0.007492:0.011203:0.005371:0.007492:0.016044:0.011682:0.003421:0.010434:0.010399:0.005679
trition and current use of nutrition support:@0.560572:0.479432:0.915150:0.479432:0.915150:0.465427:0.560572:0.465427:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434:0.007192:0.011682:0.010434:0.011716:0.007201:0.011067:0.010399:0.005148:0.005071:0.011118:0.010434:0.005798:0.007201:0.010399:0.006636:0.011118:0.007201:0.011203:0.005371:0.007201:0.010434:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434:0.007189:0.006636:0.010399:0.011665:0.011665:0.011203:0.005148:0.005798
in patients with cancer. :@0.560572:0.493120:0.763950:0.493120:0.763950:0.479115:0.560572:0.479115:0.003421:0.010434:0.006790:0.011665:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.006636:0.006790:0.014214:0.003421:0.005798:0.010434:0.006790:0.011067:0.011682:0.010434:0.011067:0.011118:0.003890:0.004738:0.004738
J Parenter Enteral:@0.766002:0.493120:0.915150:0.493120:0.915150:0.479115:0.766002:0.479115:0.008244:0.006790:0.010126:0.011682:0.005148:0.011118:0.010434:0.005798:0.011118:0.005148:0.006772:0.009168:0.010434:0.005798:0.011118:0.005148:0.011682:0.003421
Nutr:@0.560572:0.506808:0.594575:0.506808:0.594575:0.492802:0.560572:0.492802:0.012657:0.010399:0.005798:0.005148
. 2014;38(2):196-2014.:@0.594558:0.506808:0.769211:0.506808:0.769211:0.492802:0.594558:0.492802:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.004738
53.  Lee JLC, Leong LP, Lim SL. Nutrition interven-:@0.524225:0.520496:0.915231:0.520496:0.915231:0.506490:0.524225:0.506490:0.009479:0.009479:0.004738:0.012650:0.000000:0.007560:0.010776:0.010776:0.005781:0.007902:0.007560:0.013564:0.004396:0.005781:0.007560:0.010776:0.010861:0.010092:0.011169:0.005781:0.007560:0.007680:0.004396:0.005781:0.007560:0.003079:0.015702:0.005781:0.008176:0.007560:0.004396:0.005781:0.012315:0.010057:0.005456:0.004806:0.003079:0.005456:0.003079:0.010861:0.010092:0.005781:0.003079:0.010092:0.005456:0.010776:0.004806:0.009134:0.010776:0.010092:0.005679
tion approaches to reduce malnutrition in:@0.560572:0.534336:0.915140:0.534336:0.915140:0.520331:0.560572:0.520331:0.005456:0.003079:0.010861:0.010092:0.008980:0.011340:0.011323:0.011323:0.004736:0.010861:0.011340:0.010724:0.010092:0.010776:0.006294:0.008980:0.005456:0.010861:0.008980:0.004734:0.010776:0.011374:0.010057:0.010724:0.010776:0.008980:0.015702:0.011340:0.003079:0.010092:0.010057:0.005456:0.004806:0.003079:0.005456:0.003079:0.010861:0.010092:0.008980:0.003079:0.010434
oncology patients: a systematic review. :@0.560572:0.548177:0.880114:0.548177:0.880114:0.534172:0.560572:0.534172:0.010861:0.010092:0.010724:0.010861:0.003079:0.010861:0.011169:0.008826:0.004516:0.011323:0.011340:0.005456:0.003079:0.010776:0.010092:0.005456:0.006294:0.004396:0.004516:0.011340:0.004516:0.006294:0.008826:0.006294:0.005456:0.010776:0.015702:0.011340:0.005456:0.003079:0.010724:0.004516:0.004736:0.010776:0.009134:0.003079:0.010776:0.013872:0.004396:0.004738
Sup-:@0.879891:0.548177:0.915126:0.548177:0.915126:0.534172:0.879891:0.534172:0.008176:0.010057:0.011323:0.005679
portive Care in Cancer:@0.560572:0.562017:0.744495:0.562017:0.744495:0.548012:0.560572:0.548012:0.011323:0.010861:0.004806:0.005456:0.003079:0.009134:0.010776:0.004396:0.013564:0.011340:0.004806:0.010776:0.004396:0.003079:0.010092:0.004396:0.013564:0.011340:0.010092:0.010724:0.010776:0.005148
. 2016;24(1)469-480.:@0.744153:0.562017:0.898092:0.562017:0.898092:0.548012:0.744153:0.548012:0.004396:0.004396:0.009134:0.009134:0.009134:0.009134:0.004396:0.009134:0.009134:0.005969:0.009134:0.005969:0.009134:0.009134:0.009134:0.005337:0.009134:0.009134:0.009134:0.004738
54.   Caccialanza, :@0.524225:0.575858:0.677360:0.575858:0.677360:0.561853:0.524225:0.561853:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.013906:0.011682:0.011067:0.011067:0.003421:0.011682:0.003421:0.011682:0.010434:0.007269:0.011682:0.004738:0.004738
et al:@0.681825:0.575858:0.723046:0.575858:0.723046:0.561853:0.681825:0.561853:0.011118:0.005798:0.009202:0.011682:0.003421
. Nutritional support in:@0.723046:0.575858:0.915132:0.575858:0.915132:0.561853:0.723046:0.561853:0.004738:0.009202:0.012657:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010420:0.011682:0.003421:0.009202:0.006636:0.010399:0.011665:0.011665:0.011203:0.005148:0.005798:0.009202:0.003421:0.010434
cancer patients: a position paper from:@0.560572:0.589699:0.915144:0.589699:0.915144:0.575693:0.560572:0.575693:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.011665:0.011665:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.006636:0.004738:0.011665:0.011682:0.011665:0.011665:0.011203:0.006636:0.003421:0.005798:0.003421:0.011203:0.010434:0.011665:0.011665:0.011682:0.011665:0.011118:0.005148:0.011665:0.005371:0.005078:0.011203:0.016044
the  Italian Society  of  Medical Oncology:@0.560572:0.603539:0.915147:0.603539:0.915147:0.589534:0.560572:0.589534:0.005798:0.010434:0.011118:0.004738:0.005061:0.003866:0.005798:0.011682:0.003421:0.003421:0.011682:0.010434:0.009818:0.008518:0.011203:0.011067:0.003421:0.011118:0.005798:0.009168:0.004738:0.005066:0.011203:0.005371:0.004738:0.005063:0.015719:0.011118:0.011716:0.003421:0.011067:0.011682:0.003421:0.009818:0.014864:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168
(AIOM) and the Italian Society of Artificial:@0.560572:0.617380:0.915137:0.617380:0.915137:0.603375:0.560572:0.603375:0.006312:0.012657:0.003866:0.014864:0.015719:0.006312:0.006926:0.011682:0.010434:0.011716:0.006920:0.005798:0.010434:0.011118:0.006917:0.003866:0.005798:0.011682:0.003421:0.003421:0.011682:0.010434:0.006931:0.008518:0.011203:0.011067:0.003421:0.011118:0.005798:0.009168:0.006920:0.011203:0.005371:0.006924:0.012657:0.005148:0.005798:0.003421:0.004165:0.004165:0.011067:0.003421:0.011682:0.003421
Nutrition  and Metabolism (SINPE:@0.560572:0.631221:0.836499:0.631221:0.836499:0.617215:0.560572:0.617215:0.012657:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434:0.004738:0.004071:0.011682:0.010434:0.011716:0.008826:0.015719:0.011118:0.005798:0.011682:0.011665:0.011203:0.003421:0.003421:0.006636:0.016044:0.008826:0.006312:0.008518:0.003866:0.012657:0.010126:0.009168
). J Can-:@0.836499:0.631221:0.915145:0.631221:0.915145:0.617215:0.836499:0.617215:0.006312:0.004738:0.008826:0.008244:0.008826:0.013906:0.011682:0.010434:0.005679
cer:@0.560572:0.645061:0.587905:0.645061:0.587905:0.631056:0.560572:0.631056:0.011067:0.011118:0.005148
. 2016;7(2):131-135.:@0.587905:0.645061:0.743606:0.645061:0.743606:0.631056:0.587905:0.631056:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
55.   Van Bokhorst-de van der Schueren MAE,:@0.524225:0.658902:0.915171:0.658902:0.915171:0.644897:0.524225:0.644897:0.009476:0.009476:0.004738:0.012657:0.004738:-0.004738:0.010228:0.011682:0.010434:0.008980:0.009818:0.011203:0.008586:0.010434:0.011203:0.005148:0.006636:0.005798:0.005679:0.011716:0.011118:0.008980:0.009476:0.011682:0.010434:0.008980:0.011716:0.011118:0.005148:0.008980:0.008518:0.011067:0.010434:0.010399:0.011118:0.005071:0.011118:0.010434:0.008980:0.015719:0.012657:0.009168:0.004738
et al:@0.560572:0.672743:0.601913:0.672743:0.601913:0.658737:0.560572:0.658737:0.011118:0.005798:0.009322:0.011682:0.003421
. Nutrition-screening tools: does one:@0.601913:0.672743:0.915130:0.672743:0.915130:0.658737:0.601913:0.658737:0.004738:0.009322:0.012657:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011191:0.010434:0.005679:0.006636:0.011067:0.005077:0.011118:0.011118:0.010434:0.003421:0.010434:0.011511:0.009322:0.005798:0.011203:0.011203:0.003421:0.006636:0.004738:0.009322:0.011716:0.011203:0.011118:0.006636:0.009322:0.011203:0.010434:0.011118
size  fit  all?  A  systematic  review  of  screen-:@0.560572:0.686583:0.915130:0.686583:0.915130:0.672578:0.560572:0.672578:0.006636:0.003421:0.007269:0.011118:0.004738:0.002578:0.004165:0.004165:0.005798:0.004738:0.002572:0.011682:0.003421:0.003421:0.010109:0.004738:0.002579:0.012657:0.004738:0.002572:0.006636:0.009168:0.006636:0.005798:0.011118:0.016044:0.011682:0.005798:0.003421:0.011067:0.004738:0.002576:0.005078:0.011118:0.009476:0.003421:0.011118:0.014214:0.004738:0.002581:0.011203:0.005371:0.004738:0.002572:0.006636:0.011067:0.005080:0.011118:0.011118:0.010434:0.005679
ing tools for the hospital setting. :@0.560572:0.700424:0.836183:0.700424:0.836183:0.686419:0.560572:0.686419:0.003421:0.010434:0.011511:0.006893:0.005798:0.011203:0.011203:0.003421:0.006636:0.006893:0.005371:0.011203:0.005148:0.006885:0.005798:0.010434:0.011118:0.006893:0.010434:0.011203:0.006636:0.011665:0.003421:0.005798:0.011682:0.003421:0.006893:0.006636:0.011118:0.005798:0.005798:0.003421:0.010434:0.011511:0.004738:0.004738
Clin Nutr:@0.838338:0.700424:0.910416:0.700424:0.910416:0.686419:0.838338:0.686419:0.013906:0.003421:0.003421:0.010434:0.006893:0.012657:0.010399:0.005798:0.005148
.:@0.910390:0.700424:0.915128:0.700424:0.915128:0.686419:0.910390:0.686419:0.004738
2014;33:39-58.:@0.560572:0.714265:0.675222:0.714265:0.675222:0.700259:0.560572:0.700259:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
56.   Shaw C, :@0.524225:0.728105:0.631555:0.728105:0.631555:0.714100:0.524225:0.714100:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.008518:0.010434:0.011682:0.014214:0.002754:0.013906:0.004738:0.004738
et al:@0.629571:0.728105:0.664344:0.728105:0.664344:0.714100:0.629571:0.714100:0.011118:0.005798:0.002754:0.011682:0.003421
, Comparison of a novel, simple :@0.664344:0.728105:0.919883:0.728105:0.919883:0.714100:0.664344:0.714100:0.004738:0.002754:0.013906:0.011203:0.016044:0.011665:0.011682:0.005148:0.003421:0.006636:0.011203:0.010434:0.002754:0.011203:0.005371:0.002754:0.011682:0.002754:0.010434:0.011203:0.009476:0.011118:0.003421:0.004738:0.002754:0.006636:0.003421:0.016044:0.011665:0.003421:0.011118:0.004738
nutrition screening tool for adult oncology:@0.560572:0.741946:0.915150:0.741946:0.915150:0.727941:0.560572:0.727941:0.010434:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434:0.006419:0.006636:0.011067:0.005080:0.011118:0.011118:0.010434:0.003421:0.010434:0.011511:0.006423:0.005798:0.011203:0.011203:0.003421:0.006431:0.005371:0.011203:0.005148:0.006423:0.011682:0.011716:0.010399:0.003421:0.005798:0.006431:0.011203:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168
inpatients  and  the  Malnutrition  Screening:@0.560572:0.755787:0.915142:0.755787:0.915142:0.741781:0.560572:0.741781:0.003421:0.010434:0.011665:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.006636:0.004738:0.003618:0.011682:0.010434:0.011716:0.004738:0.003616:0.005798:0.010434:0.011118:0.004738:0.003612:0.015719:0.011682:0.003421:0.010434:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434:0.004738:0.003607:0.008518:0.011067:0.005077:0.011118:0.011118:0.010434:0.003421:0.010434:0.011511
Tool  (MST) against the  Patient-Generated:@0.560572:0.769627:0.915157:0.769627:0.915157:0.755622:0.560572:0.755622:0.006448:0.011203:0.011203:0.003421:0.004738:0.003394:0.006312:0.015719:0.008518:0.007286:0.006312:0.008142:0.011682:0.011511:0.011682:0.003421:0.010434:0.006636:0.005798:0.008142:0.005798:0.010434:0.011118:0.004738:0.003392:0.010126:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.005679:0.014915:0.011118:0.010434:0.011118:0.005148:0.011682:0.005798:0.011118:0.011716
Subjective Global Assessment  (PG-SGA).:@0.560572:0.783468:0.915137:0.783468:0.915137:0.769463:0.560572:0.769463:0.008518:0.010399:0.011665:0.003472:0.011118:0.011067:0.005798:0.003421:0.009476:0.011118:0.011443:0.014915:0.003421:0.011203:0.011665:0.011682:0.003421:0.011443:0.012657:0.006636:0.006636:0.011118:0.006636:0.006636:0.016044:0.011118:0.010434:0.005798:0.004738:0.006696:0.006312:0.010126:0.014915:0.005679:0.008518:0.014915:0.012657:0.006312:0.004738
Support Care Cancer:@0.560572:0.797308:0.739655:0.797308:0.739655:0.783303:0.560572:0.783303:0.008518:0.010399:0.011665:0.011665:0.011203:0.005148:0.005798:0.004738:0.013906:0.011682:0.005148:0.011118:0.004738:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148
. 2015;23:47-54.:@0.739637:0.797308:0.863764:0.797308:0.863764:0.783303:0.739637:0.783303:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
57.   Jager-Wittenaar  H,  Ottery  FD.  Assessing:@0.524225:0.811149:0.915123:0.811149:0.915123:0.797144:0.524225:0.797144:0.009476:0.009476:0.004738:0.012657:0.004738:-0.004738:0.008244:0.011682:0.011511:0.011118:0.005148:0.005679:0.016506:0.003421:0.005798:0.005798:0.011118:0.010434:0.011682:0.011682:0.005148:0.004738:0.007716:0.011682:0.004738:0.004738:0.007719:0.014864:0.005798:0.005798:0.011118:0.005148:0.009168:0.004738:0.007714:0.008296:0.012726:0.004738:0.004738:0.007719:0.012657:0.006636:0.006636:0.011118:0.006636:0.006636:0.003421:0.010434:-0.608549
nutritional  status in cancer:  role  of  the:@0.560572:0.824990:0.915149:0.824990:0.915149:0.810984:0.560572:0.810984:0.010434:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.004738:0.007360:0.006636:0.005798:0.011682:0.005798:0.010399:0.006636:0.012110:0.003421:0.010434:0.012110:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.004738:0.007357:0.005078:0.011203:0.003421:0.011118:0.004738:0.007363:0.011203:0.005371:0.004738:0.007362:0.005798:0.010434:0.011118
Patient-Generated  Subjective Global  As-:@0.560572:0.838830:0.915128:0.838830:0.915128:0.824825:0.560572:0.824825:0.010126:0.011682:0.005798:0.003421:0.011118:0.010434:0.005798:0.005679:0.014915:0.011118:0.010434:0.011118:0.005148:0.011682:0.005798:0.011118:0.011716:0.004738:0.005290:0.008518:0.010399:0.011665:0.003472:0.011118:0.011067:0.005798:0.003421:0.009476:0.011118:0.010040:0.014915:0.003421:0.011203:0.011665:0.011682:0.003421:0.004738:0.005314:0.012657:0.006636:0.005679
sessment. :@0.560572:0.852671:0.644469:0.852671:0.644469:0.838666:0.560572:0.838666:0.006636:0.011118:0.006636:0.006636:0.016044:0.011118:0.010434:0.005798:0.004738:0.004738
Curr Opin Clin Nutr Metab Care.:@0.645170:0.852671:0.915128:0.852671:0.915128:0.838666:0.645170:0.838666:0.013906:0.010399:0.005148:0.005148:0.005437:0.014864:0.011665:0.003421:0.010434:0.005456:0.013906:0.003421:0.003421:0.010434:0.005456:0.012657:0.010399:0.005798:0.005148:0.005436:0.015719:0.011118:0.005798:0.011682:0.011665:0.005427:0.013906:0.011682:0.005148:0.011118:0.004738
 :@0.863109:0.852671:0.867847:0.852671:0.867847:0.838666:0.863109:0.838666:0.004738
2017;20(5):322-329.:@0.560555:0.866512:0.716256:0.866512:0.716256:0.852506:0.560555:0.852506:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
58.   Talwar B, :@0.524208:0.880352:0.638667:0.880352:0.638667:0.866347:0.524208:0.866347:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.006397:0.011682:0.003421:0.014214:0.011682:0.005148:0.006274:0.009818:0.004738:-0.439525
et al:@0.640193:0.880352:0.678477:0.880352:0.678477:0.866347:0.640193:0.866347:0.011118:0.005798:0.006265:0.011682:0.003421
. Nutritional management in:@0.678477:0.880352:0.915104:0.880352:0.915104:0.866347:0.678477:0.866347:0.004738:0.006267:0.012657:0.010399:0.005798:0.005148:0.003421:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.006260:0.016044:0.011682:0.010434:0.011682:0.011511:0.011118:0.016044:0.011118:0.010434:0.005798:0.006258:0.003421:0.010434
head and neck cancer:  United Kingdom:@0.560555:0.894193:0.915137:0.894193:0.915137:0.880188:0.560555:0.880188:0.010434:0.011118:0.011682:0.011716:0.008244:0.011682:0.010434:0.011716:0.008244:0.010434:0.011118:0.011067:0.008586:0.008244:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.004738:0.003498:0.011203:0.010434:0.003421:0.005798:0.011118:0.011716:0.008244:0.010109:0.003421:0.010434:0.011511:0.011716:0.011203:0.016044
National Multidisciplinary Guidelines. :@0.560555:0.908034:0.871752:0.908034:0.871752:0.894028:0.560555:0.894028:0.012657:0.011682:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.007423:0.015719:0.010399:0.003421:0.005798:0.003421:0.011716:0.003421:0.006636:0.011067:0.003421:0.011665:0.003421:0.003421:0.010434:0.011699:0.005148:0.009168:0.007423:0.014915:0.010399:0.003421:0.011716:0.011118:0.003421:0.003421:0.010434:0.011118:0.006636:0.004738:0.004738
Jour-:@0.874437:0.908034:0.915111:0.908034:0.915111:0.894028:0.874437:0.894028:0.008244:0.011203:0.010399:0.005148:0.005679
nal of  Laryngology  &  Otology:@0.560555:0.921874:0.828467:0.921874:0.828467:0.907869:0.560555:0.907869:0.010434:0.011682:0.003421:0.010844:0.011203:0.005371:0.004738:0.006093:0.007902:0.011682:0.005148:0.009168:0.010434:0.011511:0.011203:0.003421:0.011203:0.011511:0.009168:0.004738:0.006087:0.012948:0.004738:0.006094:0.014864:0.005798:0.011203:0.003421:0.011203:0.011511:0.009168
.  2016;130:@0.828467:0.921874:0.915106:0.921874:0.915106:0.907869:0.828467:0.907869:0.004738:0.004738:0.006094:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476
(S2):S32-S40.:@0.560555:0.935715:0.661265:0.935715:0.661265:0.921710:0.560555:0.921710:0.006312:0.008518:0.009476:0.006312:0.004738:0.008518:0.009476:0.009476:0.005679:0.008518:0.009476:0.009476:0.004738